Nemaura Medical Inc expected to post a loss of 18 cents a share - Earnings Preview

Nemaura Medical

08/02/2023 02:30

* Nemaura Medical Inc  NMRD.OQ   NMRD.O  is expected to show
a
fall in quarterly revenue when it reports  results on February 9
(estimated). 
    * The New York City-based  company is expected to report  a
9.4% decrease in revenue to $166.67 thousand from $184 thousand
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Nemaura Medical Inc
is
for a loss of 18 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Nemaura
Medical
Inc is $8​, above​ its last closing price of $1.31. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.17       -0.17      -0.17     Met     0
 Jun. 30 2022  -0.17       -0.17      -0.17     Met     0
 Mar. 31 2022  -0.14       -0.14      -0.15     Missed  -9.8​
 Dec. 31 2021  -0.14       -0.14      -0.15     Missed  -7.1
 ​​Sep.        -0.11       -0.11      -0.15     Missed  -36.4
 30 2021                                                
 Jun. 30 2021  -0.08       -0.08      -0.14     Missed  -75​
 Mar. 31 2021              -0.08      -0.09     Missed  -12.5
 This summary was machine generated February 8 at 02:30 GMT.  All
figures in US dollars  unless otherwise stated